Jane Brody to Speak at SUNY Downstate Health Sciences University on End of Life Issues
Sep 15, 2009
Brooklyn, NY - New York Times columnist Jane Brody will be speaking at SUNY Downstate Health Sciences University on Thursday, September 17, at 8:30 a.m. Her topic is “Preparing for the End of Life Is as Important as Preserving It.”
The recipient of many honors and awards, including an honorary degree from the State University of New York, Ms. Brody writes the weekly “Personal Health” column in The New York Times.
Ms. Brody will speak as part of the Department of Medicine’s Grand Rounds program. Following her remarks, she will be signing copies of her new book, Jane Brody’s Guide to the Great Beyond.
Please note: the location of Medicine Grand Rounds, featuring New York Times columnist Jane Brody, has been changed to the Alumni Auditorium. The book signing following Grand Rounds will be held in the Atrium
### About SUNY Downstate Health Sciences University Downstate Health Sciences University in Brooklyn is one of four academic health centers
(AMCs) in The State University of New York (SUNY) 64-campus system and the only SUNY
AMC in New York City dedicated to health education, research, and patient care for
the borough’s 2.7 million residents. Its flagship hospital, University Hospital at
Downstate (UHD), is a teaching hospital and benefits from the expertise of Downstate’s
exceptional medical school and world-class academic center research facilities. With
a staff of over 800 physicians representing 53 specialties and subspecialties, Downstate
offers comprehensive healthcare services to the community. UHD provides high-risk neonatal and infant services, pediatric nephrology, and dialysis
for kidney diseases and is the only kidney transplantation program in Brooklyn. Beyond
its clinical expertise, Downstate houses a range of esteemed educational institutions,
including its College of Medicine, College of Nursing, School of Health Professions,
School of Graduate Studies, and School of Public Health. Downstate fosters innovation
through its multifaceted biotechnology initiative, the Biotechnology Incubator and
BioBAT, which support early-stage and more mature biotech companies.